Zhonghua Nei Ke Za Zhi. 2020 Jun 1;59(6):427-432. doi: 10.3760/cma.j.cn112138-20191223-00838.
Psychosomatic related disorders are diseases closely related to psychosocial factors. Patients are often treated in the non-psychiatric department of general hospitals due to somatic symptoms, and physicians often fail to recognize psychological symptoms, and could not make a proper diagnosis. Therefore, the status of diagnosis and treatment of psychosomatic disorders needs to be improved urgently. Wuling Capsule is a kind of national first class new traditional Chinese medicine with a single ingredient. It is widely used in the field of psychosomatic disorders. As an effective therapeutic drug for patients with depressive, anxious and insomnic symptoms in various departments of general hospitals, Wuling Capsule can be used alone or combined with other medications. It has fewer side effects and with higher safety. It can reduce patients' stigma and, thus, increase compliance. All these make Wuling Capsule a valuable drug in clinical application. The aim of the consensus was to summarize the clinical application situation of Wuling Capsule in psychosomatic related disorders, standardize its application in clinical practice, and provide evidence-based expert consensus recommendations for the clinical diagnosis and treatment of psychosomatic related disorders for physicians in both general and primary hospitals.
心身相关疾病是与心理社会因素密切相关的疾病。患者常因躯体症状在综合医院非精神科就诊,医生往往未能识别心理症状,无法做出正确诊断。因此,心身疾病的诊治现状亟待改善。乌灵胶囊是一种成分单一的国家一类中药新药。它在心身疾病领域广泛应用。作为综合医院各科室抑郁、焦虑及失眠症状患者的有效治疗药物,乌灵胶囊可单独使用或与其他药物联合使用。其副作用较少,安全性较高。它可减少患者的羞耻感,从而提高依从性。所有这些使得乌灵胶囊成为临床应用中有价值的药物。该共识的目的是总结乌灵胶囊在心身相关疾病中的临床应用情况,规范其在临床实践中的应用,并为综合医院和基层医院的医生在心身相关疾病的临床诊断和治疗方面提供基于证据的专家共识建议。